close

AHF Calls for Concrete Actions ahead of INB-8 Negotiations in Geneva

As the INB-8 negotiations approach, the AHF Global Public Health Institute, in partnership with the University of Miami Public Health Policy Lab, urges immediate action to ensure the WHO Pandemic Convention/Agreement genuinely strengthens global health security. Our policy brief highlights the need for equitable access to health technologies, accountability in pandemic preparedness, and the integration of civil society in decision-making processes. By addressing these critical issues, we can pave the way for a more resilient global health infrastructure. [READ HERE: https://ahfinstitute.org/wp-content/uploads/2024/02/INB-8-AHF-Institute-Key-Points-Feb-2024.pdf]

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.9 million people in 46 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. We are currently the largest non-profit provider of HIV/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Contacts

MEDIA CONTACT:

Guilherme Ferrari Faviero, JD, MS, MPH

Director, AHF Global Public Health Institute at the University of Miami

AIDS Healthcare Foundation

guilherme.faviero@ahf.org

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.16
+4.82 (2.06%)
AAPL  248.04
-0.31 (-0.12%)
AMD  259.68
+5.95 (2.35%)
BAC  51.72
-0.73 (-1.39%)
GOOG  328.43
-2.41 (-0.73%)
META  658.76
+11.13 (1.72%)
MSFT  465.95
+14.81 (3.28%)
NVDA  187.67
+2.83 (1.53%)
ORCL  177.16
-1.02 (-0.57%)
TSLA  449.06
-0.30 (-0.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today